PLN and familial dilated cardiomyopathy: Genetic correction of PLN mutations via genome editing techniques combined with gene transfer produced positive results, including normalized Ca2+ handling in a patient-derived cell model of DCM, suggesting a novel strategy for DCM treatment [39].